RA
WST icon

Resolute Advisors’s West Pharmaceutical WST Stock Holding History

Resolute Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-22
Closed -$9K – 517
2021
Q3 		$9K Hold
22
– – ﹤0.01% 360
2021
Q2 		$8K Hold
22
– – ﹤0.01% 342
2021
Q1 		$5K Buy
+22
New +$6.3K ﹤0.01% 341

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Resolute Advisors's WST Position: Q4 2021 in Review

Resolute Advisors sold out of West Pharmaceutical (WST) in Q4 2021, closing a stake of 22 shares — an estimated $9K sold.

Resolute Advisors first reported a position in WST in Q1 2021 and held it in 3 quarters. The position peaked at $9K in Q3 2021. 729 funds tracked by Wall St. Rank hold WST as of Q4 2021.

  • Resolute Advisors reported no remaining West Pharmaceutical position as of Q4 2021 after selling out during the quarter.
  • Resolute Advisors sold 22 West Pharmaceutical shares in Q4 2021, an estimated $9K.
  • Resolute Advisors first reported a position in West Pharmaceutical in Q1 2021 and held it in 3 quarters.
  • Resolute Advisors's West Pharmaceutical position peaked at $9K in Q3 2021.
  • 729 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2021.

Based on Resolute Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.